Want to see PTGX full AI Analyst Report?
Protagonist Therapeutics (PTGX) Ownership Overview
1.18% Insiders
26.44% Mutual Funds
41.52% Other Institutional Investors
27.04% ETFs
3.82% Public Companies and
Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 95.00% of the company’s stock is owned by Institutional Investors, 1.18% is owned by Insiders, and 3.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 12, 2026 | xxxxxxxxxxxxx | $14890799 | |
Jun 25, 2026 | xxxxxxxxxxxxx | $1061460 | |
Jun 11, 2026 | xxxxxxxxxxxxx | $969120 | |
Jun 01, 2026 | xxxxxxxxxxxxx | $896760 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $120358728 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $89612477 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $25606962 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $20902832 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,396,035 | Institution | 11.43% | 1,077,750,220 | |
| 6,348,906 | Institution | 9.81% | 925,162,582 | |
| 5,999,237 | Institution | 9.27% | 874,208,816 | |
| 4,987,694 | Institution | 7.71% | 726,806,770 | |
| 2,166,358 | Institution | 3.35% | 315,681,688 | |
| 1,414,173 | Institution | 2.19% | 206,073,290 | |
| 1,380,445 | Institution | 2.13% | 201,158,445 | |
| 1,142,059 | Institution | 1.76% | 166,420,837 | |
| 994,349 | Institution | 1.54% | 144,896,536 | |
| 981,879 | Institution | 1.52% | 143,079,408 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,987,694 | Institution | 7.71% | 726,806,770 | |
| 1,380,445 | Institution | 2.13% | 201,158,445 | |
| 1,142,059 | Institution | 1.76% | 166,420,837 | |
| 994,349 | Institution | 1.54% | 144,896,536 | |
| 784,139 | Institution | 1.21% | 114,264,735 | |
| 591,708 | Institution | 0.91% | 86,223,690 | |
| 506,713 | Institution | 0.78% | 73,838,218 | |
| 445,248 | Institution | 0.69% | 64,881,539 | |
| 443,603 | Institution | 0.69% | 64,641,829 | |
| 406,743 | Institution | 0.63% | 59,270,590 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,686,627 | Institution | 5.70% | 537,215,286 | |
| 2,052,184 | Institution | 3.17% | 280,410,422 | |
| 1,577,095 | Institution | 2.44% | 229,814,283 | |
| 1,475,028 | Institution | 2.28% | 180,808,932 | |
| 1,001,250 | Institution | 1.55% | 148,986,000 | |
| 855,894 | Institution | 1.32% | 116,949,356 | |
| 696,004 | Institution | 1.08% | 95,101,987 | |
| 577,963 | Institution | 0.89% | 84,220,768 | |
| 572,937 | Institution | 0.89% | 83,488,380 | |
| 572,505 | Institution | 0.88% | 83,425,429 |
FAQ
Who Owns Protagonist Therapeutics (PTGX)?
According to the latest TipRanks data, approximately 41.52% of the company's stock is held by institutional investors, 1.18% is held by insiders, and 3.82% is held by retail investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 41.52% of Protagonist Therapeutics (PTGX) stock is held by institutional investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by retail investors?
According to the latest TipRanks data, approximately 3.82% of Protagonist Therapeutics (PTGX) stock is held by retail investors.
Who owns the most shares of Protagonist Therapeutics (PTGX)?
iShares owns the most shares of Protagonist Therapeutics (PTGX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.